At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
HIV/AIDS
HIV/AIDS
-
-
Fighting the Syndemic: Addressing Opioid Use Disorder and Decreasing HIV Go Hand-in- Hand
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV. -
Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH. -
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady. -
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Latest News
Amid US Blood Shortage, New Pressure to Ease Donor Rules for Gay Men
A three-month sexual abstinence rule for blood donations from sexually active gay and bisexual men should be dropped by the U.S. Food and Drug Administration.
Outcomes of a Multicomponent Diagnostic Strategy for Tuberculosis Infection
Researchers conducted a study that compared a multicomponent diagnostic strategy with routine care for the diagnosis and treatment of tuberculosis infection.
HIV PrEP and Treatment Not Reaching Black and Hispanic/Latino Gay and Bisexual Men
The first injectable PrEP option for HIV may help reduce inequities among Black and Hispanic/Latino gay and bisexual men.
Zoledronate and Denosumab in Men With HIV on Antiretroviral Therapy
Antiretroviral therapy taken by people living with HIV decreases bone mineral density and increases fracture risk. Researchers investigated whether osteoporosis drugs denosumab and zolendronate could help men living with both osteoporosis and HIV.
Cash Transfers, Incentives for School Attendance May Decrease Incident HIV Risk in Women, Girls
Researchers conducted a study to determine whether government cash programs and programs that incentivize school attendance decrease the incidence of HIV infection among young women and adolescent girls.
Outcomes of Dolutegravir Treatment in Patients With HIV Infection Who Failed Antiretroviral Therapy
Researchers conducted a study to determine effect of a dolutegravir-based treatment regimen in patients with HIV infection.
Effect of Buprenorphine on Viral Suppression in Patients With HIV Infection
Researchers conducted a study among patients with HIV infection to assess the effect of buprenorphine on HIV viral loads.
FDA Approves Apretude, a Long-Acting Injectable for HIV PrEP
The application is supported by data from the phase 2b/3 HPTN 083 and HPTN 084 trials, which evaluated the efficacy and safety of Apretude for HIV PrEP.
Pediatricians Can Play Key Role in HIV Testing, Prophylaxis
In a clinical report, recommendations are presented for addressing HIV testing and preexposure and postexposure HIV prophylaxis in adolescents and young adults.
Number of Older People With HIV on ART Projected to Increase
If expected patterns in HIV diagnosis and survival continue, an estimated 23% of ART users in the year 2030 will be 65 years of age or older.
Transgender Individuals Have an Increased HIV Burden
Transfeminine and transmasculine individuals are disproportionately burdened by HIV.
Children Lagging in Global Goal to Achieve HIV Suppression
A considerable proportion of people with HIV do not achieve long-term viral suppression, with fewer children and adolescents achieving viral suppression than adults.
Clinical Guidelines Updated for HIV Pre-Exposure Prophylaxis
Updates include recommendation to provide all sexually active patients with information about PrEP, use of cabotegravir injections for PrEP.
Biden’s New HIV/AIDS Strategy Calls Racism a Roadblock to Victory
Racism is “a public health threat” that must be tackled to end the global HIV/AIDS epidemic.
WHO Approves First Long-Acting Device to Shield Women From HIV
With HIV a continuing threat to women’s health, the World Health Organization has approved the first long-acting device to protect women from sexually transmitted HIV.
Patient May Have Naturally Achieved a Sterilizing Cure for HIV Infection
Researchers evaluated the virologic and immunologic characteristics of a patient with previously confirmed HIV infection who had an undetectable HIV viral load for more than 7 years after discontinuing antiretroviral therapy.
Effects of HIV Pre-Exposure Prophylaxis on High-Risk Sexual Behaviors in Men Who Have Sex With Men
Investigators conducted a study to assess the rates of high-risk sexual behavior and sexually transmitted infections among men who have sex with men before and after the introduction of HIV pre-exposure prophylaxis.
Cerebrospinal Fluid vs Plasma HIV RNA Viral Loads in Patients With Untreated HIV Infection
Researchers conducted a study to determine whether patients with untreated HIV infection have consistently decreased cerebrospinal fluid HIV RNA viral loads vs plasma HIV RNA throughout various stages of the disease.
Hypertension Risk Factors in Young Adults With Perinatal HIV Infection
Researchers conducted a study to determine the socio-demographic, clinical, virologic, and immunologic risk factors associated with systemic hypertension in patients with perinatal HIV infection.
Optimal Dosing of Rifampicin/Isoniazid/Pyrazinamide in Children With Tuberculosis
Investigators conducted a study to determine the optimal fixed-dose combination of rifampicin/isoniazid/pyrazinamide in children with tuberculosis infection.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in HIV/AIDS
Loading... 
Loading...